Cargando…

Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate

Pharmacotherapies for the treatment of Benign Prostatic Hyperplasia (BPH) are targeted at reducing cellular proliferation (static component) or reducing smooth muscle tone (dynamic component), but response is unpredictable and many patients fail to respond. An impediment to identifying novel pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sophie N., Kraska, Jenna, Papargiris, Melissa, Teng, Linda, Niranjan, Birunthi, Hammar, Johanna, Ryan, Andrew, Frydenberg, Mark, Lawrentschuk, Nathan, Middendorff, Ralf, Ellem, Stuart J., Whittaker, Michael, Risbridger, Gail P., Exintaris, Betty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973579/
https://www.ncbi.nlm.nih.gov/pubmed/33737570
http://dx.doi.org/10.1038/s41598-021-85439-4